Organigram (NASDAQ:OGI) Announces Quarterly Earnings Results

Organigram (NASDAQ:OGI) issued its earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02), Zacks reports. Organigram had a negative return on equity of 11.68% and a negative net margin of 28.58%.

Organigram Stock Performance

NASDAQ:OGI opened at $1.73 on Tuesday. The stock’s 50-day moving average is $1.56 and its 200-day moving average is $1.67. Organigram has a 1-year low of $1.31 and a 1-year high of $2.91.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.